Literature DB >> 26517405

Lack of Association Between Corneal Hysteresis and Corneal Resistance Factor With Glaucoma Severity in Primary Angle Closure Glaucoma.

Monisha E Nongpiur1, Monisha E Nongpiur1, Owen Png2, Jestin W Chiew3, Kenric R Fan3, Michael J A Girard4, Tina Wong5, David Goh6, Shamira A Perera6, Tin Aung7.   

Abstract

PURPOSE: We investigated the association between corneal hysteresis (CH) and corneal resistance factor (CRF) with glaucoma severity in primary angle closure glaucoma (PACG).
METHODS: We recruited 204 subjects with PACG. Each subject underwent CH and CRF measurements using the Ocular Response Analyzer (ORA), optic nerve head topography measurement using scanning laser ophthalmoscopy, and visual field assessment. Glaucoma severity was based on the visual field mean deviation (MD) and classified as mild (71), moderate (55), and severe (78).
RESULTS: The mean age ± SD of study subjects was 68.7 ± 8.9 years, with most being Chinese (n = 186; 91.2%). Corneal hysteresis and CRF were lowest in the severe PACG group (9.32 ± 1.86 and 9.50 ± 1.67 mm Hg) followed by moderate PACG (9.38 ± 1.88 and 9.73 ± 1.88 mm Hg) and mild PACG (9.47 ± 1.90 and 9.85 ± 1.75 mm Hg) respectively, but the differences were not significant (P = 0.89 and P = 0.46, respectively). There was a significant positive correlation between CH and central corneal thickness (CCT; correlation coefficient [r] = 0.26, P < 0.001), CRF and CCT (r = 0.43, P < 0.001), and negative correlation between CRF and vertical cup-disc ratio (VCDR; r = -0.20, P = 0.004), and CRF with cup-disc area (r = -0.14, P = 0.04). Corneal hysteresis and CRF were not correlated with MD (r = 0.01 for CH, r = 0.1 for CRF). After multivariate analyses, adjusting for age, sex, CCT, axial length, intraocular pressure, and number of glaucoma medication, no significant associations were noted between CH and CRF with MD, VCDR, disc area, rim area, or cup area.
CONCLUSIONS: Corneal biomechanical parameters measured by the ORA are not associated with severity of glaucoma in PACG.

Entities:  

Mesh:

Year:  2015        PMID: 26517405     DOI: 10.1167/iovs.15-17930

Source DB:  PubMed          Journal:  Invest Ophthalmol Vis Sci        ISSN: 0146-0404            Impact factor:   4.799


  7 in total

1.  Corneal hysteresis and anterior segment optical coherence tomography anatomical parameters in primary angle closure suspects.

Authors:  Syed Amal Hussnain; Kyle D Kovacs; Joshua L Warren; Christopher C Teng
Journal:  Clin Exp Ophthalmol       Date:  2018-01-11       Impact factor: 4.207

Review 2.  Corneal Hysteresis, Intraocular Pressure, and Progression of Glaucoma: Time for a "Hyst-Oric" Change in Clinical Practice?

Authors:  Patrick Murtagh; Colm O'Brien
Journal:  J Clin Med       Date:  2022-05-20       Impact factor: 4.964

3.  The Effect of Axial Length Elongation on Corneal Biomechanical Property.

Authors:  Guihua Liu; Hua Rong; Ping Zhang; Yu Xue; Bei Du; Biying Wang; Jiamei Hu; Zhi Chen; Ruihua Wei
Journal:  Front Bioeng Biotechnol       Date:  2021-12-02

4.  Corvis Biomechanical Factor Facilitates the Detection of Primary Angle Closure Glaucoma.

Authors:  Chien-Chih Chou; Po-Jen Shih; Chun-Yuan Wang; Tzuu-Shuh Jou; Jun-Peng Chen; I-Jong Wang
Journal:  Transl Vis Sci Technol       Date:  2022-10-03       Impact factor: 3.048

5.  Effects of phacoemulsification and intraocular lens implantation combined with ciliarotomy in the treatment of angle-closure glaucoma with cataract.

Authors:  Bo Li; Feng-Yun Wang; Tai-Liang Lv; Yu Zhu
Journal:  Exp Ther Med       Date:  2016-08-30       Impact factor: 2.447

6.  Corneal Factors Associated with the Amount of Visual Field Damage in Eyes with Newly Diagnosed, Untreated, Open-angle Glaucoma.

Authors:  Gema Bolivar; Cristina Sanchez-Barahona; Samira Ketabi; Vassilios Kozobolis; Miguel A Teus
Journal:  Ophthalmol Ther       Date:  2021-07-19

7.  In vivo assessment of changes in corneal hysteresis and lamina cribrosa position during acute intraocular pressure elevation in eyes with markedly asymmetrical glaucoma.

Authors:  Corrado Gizzi; Mauro Cellini; Emilio C Campos
Journal:  Clin Ophthalmol       Date:  2018-03-15
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.